Biosensors & bioelectronics

(ISSN: 0956-5663, 1873-4235)

Table of Contents

2022 - 199

  • Highly sensitive and quantitative biodetection with lipid-polymer hybrid nanoparticles having organic room-temperature phosphorescence. 
  • Development of three-dimensional semi-solid hydrogel matrices for ratiometric fluorescence sensing of Amyloid β peptide and imaging in SH-SY5 cells: Improvement of point of care diagnosis of Alzheimer's disease biomarker. 
  • Portable electrochemical biosensor based on laser-induced graphene and MnO2 switch-bridged DNA signal amplification for sensitive detection of pesticide. 
  • The development of real-time digital PCR technology using an improved data classification method. 
  • Aptamer duo-based portable electrochemical biosensors for early diagnosis of periodontal disease. 
  • Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody. 
  • Quantum dots' size matters for balancing their quantity and quality in label materials to improve lateral flow immunoassay performance for C-reactive protein determination. 
  • Development of a novel liquid crystal Apta-sensing platform using P-shape molecular switch. 
  • Artificial intelligence-assisted enumeration of ultra-small viruses with dual dark-field plasmon resonance probes. 
  • An equivalent circuit model for localized electroporation on porous substrates. 
  • Extending lifetime of gas-phase odor biosensor using liquid thickness control and liquid exchange. 
  • Wearable sensors made with solution-blow spinning poly(lactic acid) for non-enzymatic pesticide detection in agriculture and food safety. 
  • Highly sensitive and selective nanostructured microbiosensors for glucose and lactate simultaneous measurements in blood serum and in vivo in brain tissue. 
  • Prediction of acute rejection in kidney transplanted patients based on the point-of-care isothermal molecular diagnostics platform. 
  • Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination. 
  • Amplifiable ratiometric fluorescence biosensing of nanosilver multiclusters populated in three-way-junction DNA branches. 
  • Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid β peptides and their dynamic aggregation process. 
  • RNA polymerization actuating nucleic acid membrane (RANAM)-based biosensing for universal RNA virus detection. 
  • Graphene-based hybrid electrical-electrochemical point-of-care device for serologic COVID-19 diagnosis. 
  • Genetic regulatory element based whole-cell biosensors for the detection of metabolic disorders. 
  • Rapid enrichment and sensitive detection of extracellular vesicles through measuring the phospholipids and transmembrane protein in a microfluidic chip. 
  • Facile and foldable point-of-care biochip for nucleic acid based-colorimetric detection of murine norovirus in fecal samples using G-quadruplex and graphene oxide coated microbeads. 
  • Standard cochlear implants as electrochemical sensors: Intracochlear oxygen measurements in vivo. 
  • Instrument-free, CRISPR-based diagnostics of SARS-CoV-2 using self-contained microfluidic system. 
  • A pretreatment-free electrical capacitance biosensor for exosome detection in undiluted serum. 
  • An AC electrokinetics-based electrochemical aptasensor for the rapid detection of microRNA-155. 
  • Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips. 
  • Reusable smartphone-facilitated mobile fluorescence biosensor for rapid and sensitive on-site quantitative detection of trace pollutants. 
  • Rapid and sensitive detection of Staphylococcus aureus by using a long-period fiber grating immunosensor coated with egg yolk antibody. 
  • Metal-organic frameworks based hybrid nanocomposites as state-of-the-art analytical tools for electrochemical sensing applications. 
  • Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. 
 
 

Journal Information